Give me All lesion classification on FNAC

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Loading Image
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
I now have comprehensive data from multiple authoritative textbooks. Let me compile the complete answer:

FNAC (Fine Needle Aspiration Cytology) - All Lesion Classification Systems

FNAC reporting has been standardized by organ-specific classification systems. Below are all the major classifications used worldwide.

1. THYROID FNAC Classifications

A. The Bethesda System for Reporting Thyroid Cytopathology (BSRTC) - 2023 (3rd edition)

The most widely used international standard, developed by the National Cancer Institute. Six tiered categories:
Bethesda CategoryDiagnosisRisk of Malignancy (NIFTP ≠ cancer)Risk of Malignancy (NIFTP = cancer)Usual Management
INondiagnostic / Unsatisfactory5%-18%5%-20%Repeat FNA with ultrasound guidance
IIBenign0%-4%2%-7%Clinical and sonographic follow-up
IIIAtypia of Undetermined Significance (AUS) / Follicular Lesion of Undetermined Significance (FLUS)6%-24%~13%-30%Repeat FNA, molecular testing, or lobectomy
IVFollicular Neoplasm (FN) / Suspicious for Follicular Neoplasm17%-28%23%-34%Molecular testing or lobectomy
VSuspicious for Malignancy58%-74%67%-83%Near-total thyroidectomy or lobectomy
VIMalignant94%-96%97%-100%Near-total thyroidectomy or lobectomy
NIFTP = Noninvasive Follicular Thyroid Neoplasm with Papillary-like nuclear features
  • Source: Sabiston Textbook of Surgery, Table 73.3
Category VI (Malignant) includes: Papillary thyroid carcinoma, medullary carcinoma, poorly differentiated carcinoma, undifferentiated (anaplastic) carcinoma, squamous cell carcinoma, carcinoma with mixed features, metastatic carcinoma, and non-Hodgkin lymphoma.

B. BTA/RCPath "Thy" System (UK)

The British Thyroid Association / Royal College of Pathologists system:
CodeCytological DiagnosisManagement
Thy1Non-diagnosticUS assessment +/- repeat FNAB
Thy1cNon-diagnostic - cystic lesionRepeat or clinical correlation
Thy2Non-neoplastic (benign)Correlate with clinical/US findings
Thy2cNon-neoplastic - cystic lesionCorrelate clinically
Thy3aNeoplasm possible - atypia (uncategorized)Further US +/- repeat FNAB
Thy3fNeoplasm possible - possible follicular neoplasmDiagnostic hemithyroidectomy
Thy4Suspicious of malignancyDiagnostic hemithyroidectomy
Thy5Diagnostic of malignancy (Malignant)Surgical resection / near-total thyroidectomy
  • Source: Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol 1; Bailey & Love's Short Practice of Surgery 28th Ed.

C. Italian TIR System

CodeDiagnosisRisk of Malignancy
TIR 1Non-diagnostic-
TIR 1cNon-diagnostic cystic-
TIR 2Non-malignant<3%
TIR 3ALow Risk Indeterminate Lesion (LRIL)<10%
TIR 3BHigh Risk Indeterminate Lesion (HRIL)15%-30%
TIR 4Suspicious of malignancy60%-80%
TIR 5Malignant>95%

D. Japanese System

CodeDiagnosisRisk of Malignancy
1Inadequate~10%
2Normal or benign<1%
3AFollicular neoplasm A-1 (favour benign)<15%
3AFollicular neoplasm A-2 (borderline)15%-30%
3AFollicular neoplasm A-3 (favour malignant)40%-60%
3BIndeterminate - Others40%-60%
4Malignancy suspected>80%
5Malignant-

E. Australian System

CodeDiagnosisRisk of Malignancy
1Non-diagnostic0%-10%
2Benign0%-3%
3Indeterminate / follicular lesion of undetermined significance5%-15%
4Suggestive of a follicular neoplasm15%-30%
5Suspicious of malignancy60%-75%
6Malignant>97%
  • All thyroid comparison data from: Scott-Brown's Otorhinolaryngology, Table 58.1

2. SALIVARY GLAND FNAC - Milan System

Proposed by an international panel of experts (American Society of Cytopathology and International Academy of Cytology). Six categories:
CategoryDiagnosisRisk of MalignancyUsual Management
INon-diagnostic25%Clinical/radiological correlation; repeat FNAC
IINon-neoplastic10%Clinical follow-up and radiological correlation
IIIAtypia of Undetermined Significance (AUS)20%Repeat FNAC or surgery
IVABenign Neoplasm<5%Conservative surgery or clinical follow-up
IVBSalivary Gland Neoplasm of Uncertain Malignant Potential (SUMP)35%Conservative surgery*
VSuspicious for malignancy60%Surgery*
VIMalignant>90%Surgery* (extent depends on type and grade)
Intraoperative frozen section may help determine extent of surgery
  • Source: Bailey & Love's Short Practice of Surgery 28th Ed., Table 54.4; Cummings Otolaryngology Head & Neck Surgery
Category details:
  • Non-neoplastic (II): Includes inflammatory, metaplastic, and reactive processes - requires clinicoradiologic correlation
  • AUS (III): Reactive atypia or poorly sampled neoplasms - requires repeat FNA or surgery
  • Benign Neoplasm (IVA): Clear-cut benign neoplasms (e.g. pleomorphic adenoma, Warthin tumour)
  • SUMP (IVB): Neoplasm identified but specific entity cannot be determined and malignancy cannot be excluded

3. CERVICAL / ANAL CYTOLOGY - Bethesda Classification

CategoryMeaning
Negative for Intraepithelial Lesion or Malignancy (NILM)Normal / reactive changes
ASC-USAtypical Squamous Cells of Undetermined Significance
ASC-HAtypical Squamous Cells - cannot exclude HSIL
LSILLow-Grade Squamous Intraepithelial Lesion (CIN 1, HPV effect)
HSILHigh-Grade Squamous Intraepithelial Lesion (CIN 2/3)
SCCSquamous Cell Carcinoma
AGCAtypical Glandular Cells
AISAdenocarcinoma in Situ
AdenocarcinomaMalignant glandular lesion
The same Bethesda classification is applied to anal cytology with parallel terminology.
  • Source: Tietz Textbook of Laboratory Medicine 7th Ed.; Pfenninger and Fowler's Procedures for Primary Care

4. BREAST FNAC - UK/NHS Classification (C-coding)

The standard UK breast FNAC reporting uses a 5-tier C-code system:
CodeCategoryDescription
C1Inadequate/Non-diagnosticInsufficient material for diagnosis
C2BenignBenign epithelial cells, no malignant features
C3Atypia - probably benignAtypical cells but most likely benign (equivocal)
C4Suspicious - probably malignantAtypical cells with high suspicion of malignancy
C5MalignantDiagnostic of malignancy
Note: Breast FNAC is increasingly being supplemented or replaced by core biopsy, which provides architectural assessment and allows ER/PR/HER2 receptor testing.

5. GENERAL / GENERIC FNAC Classification

For non-organ-specific or general purpose reporting, the following broad five-tier scheme is used in many centers:
CategoryDescription
UnsatisfactoryInsufficient cells for diagnosis; <6 follicles of 10+ cells (thyroid equivalent)
Benign / Non-neoplasticNo evidence of malignancy; benign features
Indeterminate / AtypicalEquivocal; cannot classify as clearly benign or malignant
Suspicious of malignancyFeatures highly suggestive but not diagnostic of malignancy
MalignantDiagnostic of malignancy (specify type: carcinoma, lymphoma, sarcoma, etc.)

Histological Cytological Images - Bethesda Thyroid Categories

Cytologic features of thyroid FNA across Bethesda categories
Representative cytologic features by Bethesda category: (A) Cat. II - benign colloid nodule with bland follicular cells in macrofollicular pattern; (B) Cat. III - AUS with nuclear enlargement and occasional intranuclear grooves; (C) Cat. IV - follicular neoplasm with highly cellular aspirate in microfollicles; (D) Cat. V - suspicious for PTC with nuclear enlargement and pale chromatin; (E) Cat. VI - PTC with "Orphan Annie eye" nuclei and intranuclear pseudoinclusions.
  • Source: Sabiston Textbook of Surgery

Summary Table - FNAC Classification Systems by Organ

Organ / SiteClassification SystemNo. of Categories
ThyroidBethesda System (BSRTC) - International6
ThyroidBTA/RCPath Thy System - UK6 (Thy1-Thy5 + subcategories)
ThyroidItalian TIR System6
ThyroidJapanese System5
ThyroidAustralian System6
Salivary GlandMilan System6 (I-VI)
BreastC-coding System (UK/NHS)5 (C1-C5)
Cervix / AnalBethesda Cervical ClassificationMultiple (NILM, ASC-US, LSIL, HSIL, etc.)
General / GenericFive-tier scheme5

Key Clinical Principle: Regardless of organ system, all FNAC classification systems share the same fundamental principle - stratifying lesions by risk of malignancy to guide clinical management (repeat FNA, observation, surgery). The non-diagnostic and indeterminate categories are the most clinically challenging and often require additional workup (repeat FNA, molecular testing, or core biopsy).
Sources: Bailey & Love's Short Practice of Surgery 28th Ed. | Sabiston Textbook of Surgery | Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol. 1 | Cummings Otolaryngology Head & Neck Surgery | Tietz Textbook of Laboratory Medicine 7th Ed.

Nodules swelling below right ear since one month on aspiration sorrows metrical can ?

Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Microscopy shows occasional lymphocytes with occasional cyst macrophage against proteinaceous background.

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Create a diagnostic flowchart for neck cysts with FNAC findings

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.